ArQule, Inc. To Present At The Leerink Partners Rare Disease And Immuno-Oncology Roundtable On September 28, 2016

BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September 28th, 2016, at 4:10 p.m. ET at the Lotte New York Palace in New York, New York.
MORE ON THIS TOPIC